1. Home
  2. KSCP vs LPCN Comparison

KSCP vs LPCN Comparison

Compare KSCP & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Knightscope Inc.

KSCP

Knightscope Inc.

HOLD

Current Price

$3.58

Market Cap

58.1M

ML Signal

HOLD

Logo Lipocine Inc.

LPCN

Lipocine Inc.

HOLD

Current Price

$7.58

Market Cap

61.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KSCP
LPCN
Founded
2013
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.1M
61.8M
IPO Year
2022
2011

Fundamental Metrics

Financial Performance
Metric
KSCP
LPCN
Price
$3.58
$7.58
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$16.67
$15.00
AVG Volume (30 Days)
576.8K
96.6K
Earning Date
05-13-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
63.54
46.18
EPS
N/A
N/A
Revenue
$11,335,000.00
$1,976,677.00
Revenue This Year
$9.63
N/A
Revenue Next Year
$31.03
$74.43
P/E Ratio
N/A
N/A
Revenue Growth
4.91
N/A
52 Week Low
$2.46
$2.52
52 Week High
$10.13
$12.37

Technical Indicators

Market Signals
Indicator
KSCP
LPCN
Relative Strength Index (RSI) 41.32 46.08
Support Level $2.92 $2.87
Resistance Level $4.50 $8.35
Average True Range (ATR) 0.48 0.68
MACD 0.02 -0.00
Stochastic Oscillator 6.09 29.30

Price Performance

Historical Comparison
KSCP
LPCN

About KSCP Knightscope Inc.

Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: